Healthcare
Live Price
Offline$1.42
-1.39% today
1Y Change
+13.60%
Window
Jun 20, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 20, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SNDL Inc. (SNDL) is a Healthcare stock with a market cap of $500.00M and listed on NASDAQ. The stock last traded around $1.42 and up 13.6% across the available one-year price window (Jun 20, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +2.8%, EPS growth of +84.1%, a dividend yield of 0.0%. What stands out right now is revenue +2.8%, EPS +84.1%, free cash flow +32.4% with operating margin -0.8% and ROIC -0.5%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Stock Foundry combines SNDL price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SNDL
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SNDL Max Drawdown
-54.17%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SNDL and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$56.1M
-92.1% YoY
FY Net Income
-$227.0M
+32.3% YoY
Free Cash Flow
-$159.2M
-806.1% YoY
Revenue Growth
+2.8%
EPS Growth
+84.1%
Gross Margin
27.2%
Net Margin
-1.2%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 946M | 920M | 909M | 712M | 56M |
| Gross Profit | 259M | 240M | 190M | 140M | -9M |
| Operating Income | -4M | -104M | -163M | -348M | -134M |
| EBITDA | 47M | -41M | -99M | -327M | -224M |
| Net Income | -16M | -95M | -173M | -335M | -227M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 273M | 218M | 195M | 280M | 558M |
| Total Assets | 1.3B | 1.3B | 1.5B | 1.6B | 1.4B |
| Total Liabilities | 235M | 216M | 244M | 232M | 98M |
| Shareholder Equity | 1.1B | 1.1B | 1.2B | 1.3B | 1.3B |
| Total Debt | 170M | 152M | 167M | 170M | 33M |
| Net Debt | -102M | -66M | -28M | -110M | -525M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
155M
-2216.2% YoY
Capital Expenditures
4M
+65.1% YoY
Free Cash Flow
159M
-806.1% YoY
Key ratios
Gross Margin
27.2%
Operating Margin
-0.8%
Net Margin
-1.2%
ROE
-1.0%
Debt / Equity
0.15x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.